Correlation Between Akari Therapeutics and Instil Bio

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Akari Therapeutics and Instil Bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Akari Therapeutics and Instil Bio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Akari Therapeutics PLC and Instil Bio, you can compare the effects of market volatilities on Akari Therapeutics and Instil Bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Akari Therapeutics with a short position of Instil Bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Akari Therapeutics and Instil Bio.

Diversification Opportunities for Akari Therapeutics and Instil Bio

0.14
  Correlation Coefficient

Average diversification

The 3 months correlation between Akari and Instil is 0.14. Overlapping area represents the amount of risk that can be diversified away by holding Akari Therapeutics PLC and Instil Bio in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Instil Bio and Akari Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Akari Therapeutics PLC are associated (or correlated) with Instil Bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Instil Bio has no effect on the direction of Akari Therapeutics i.e., Akari Therapeutics and Instil Bio go up and down completely randomly.

Pair Corralation between Akari Therapeutics and Instil Bio

Given the investment horizon of 90 days Akari Therapeutics PLC is expected to under-perform the Instil Bio. In addition to that, Akari Therapeutics is 1.54 times more volatile than Instil Bio. It trades about -0.25 of its total potential returns per unit of risk. Instil Bio is currently generating about -0.18 per unit of volatility. If you would invest  3,529  in Instil Bio on August 29, 2024 and sell it today you would lose (986.00) from holding Instil Bio or give up 27.94% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Akari Therapeutics PLC  vs.  Instil Bio

 Performance 
       Timeline  
Akari Therapeutics PLC 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Akari Therapeutics PLC has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.
Instil Bio 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Instil Bio are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Despite quite weak forward indicators, Instil Bio disclosed solid returns over the last few months and may actually be approaching a breakup point.

Akari Therapeutics and Instil Bio Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Akari Therapeutics and Instil Bio

The main advantage of trading using opposite Akari Therapeutics and Instil Bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Akari Therapeutics position performs unexpectedly, Instil Bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Instil Bio will offset losses from the drop in Instil Bio's long position.
The idea behind Akari Therapeutics PLC and Instil Bio pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.

Other Complementary Tools

FinTech Suite
Use AI to screen and filter profitable investment opportunities
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Equity Valuation
Check real value of public entities based on technical and fundamental data